HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

OPTIMIZATION OF PERSONALIZED THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE

DOI: https://doi.org/10.29296/25877305-2018-02-17
Download full text PDF
Issue: 
2
Year: 
2018

Professor V. Kukes (1), MD, Academician of the Russian Academy of Sciences; Professor E. Shikh (1), MD, A. Zhestovskaya (1), Professor A. Prokofyev (1, 2), MD; Professor V. Drozdov (1), MD; V. Smirnov (1, 2), Candidate of Pharmaceutical Sciences; L. Pavlova (1), Candidate of Medical Sciences 1-I.M. Sechenov First Moscow State Medical University (Sechenov University) 2-Research Center for Examination of Medical Products, Moscow

Six-minute walk tests showed that the incorporation of ethylmethylhydroxypyridine malate (100 mg/day intravenously) into the treatment regimen for chronic heart failure (CHF) allowed a significantly (p=0.04) greater number (33.3%) of patients to have a lower functional class of CHF (17.8% of those receiving the standard treatment regimen).

Keywords: 
cardiology
chronic heart failure
ethylmethylhydroxypyridine malate (Ethoxydol)
6-minute walk test



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. VOZ. Informatsionnyj bjulleten' №317. Janvar' 2015 g.
  2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC // Eur. Heart J. – 2016; 37 (27): 2129–200. DOI: 10.1093/eurheartj/ehw128.
  3. Luk'janova L.D. Sovremennye problemy i perspektivy farmakologicheskoj korrektsii gipoksicheskih sostojanij. V kn. Farmakoterapija v nevrologii i psihiatrii / M., 2002; s. 22–34.
  4. Smirnov A.V., Krivoruchko B.I. Antigipoksanty v neotlozhnoj meditsine // Anesteziologija i reanimatologija. – 1998; 2: 50–5.
  5. Sullivan M., Higginbotham M., Cobb F. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance // Circulation. – 1989; 79 (2): 324–9. DOI: 10.1161/01.CIR.79.2.324.
  6. Luk'janova L.D. Novye podhody k sozdaniju antigipoksantov metabolicheskogo dejstvija // Vestn. RAMN. – 1999; 3: 18–25.
  7. Luk'janchuk V.D., Savchenkova L.V. Antigipoksanty: sostojanie i perspektivy // Eksperim. i klin. farmakol. – 1998; 61 (4): 72–9.
  8. Gatsura V.V. Farmakologicheskaja korrektsija energeticheskogo obmena ishemizirovannogo miokarda / M.: «Anteks», 1993; 254 s.
  9. Kukes V.G., Prokof'ev A.B., Goroshko O.A. i dr. Vlijanie etilmetilgidroksipiridina malata na naprjazhenie kisloroda v krovi u patsientov s hronicheskoj serdechnoj nedostatochnost'ju // Lekarstvennye sredstva i rats. farmakoter. – 2013; 3: 18–22.